Literature DB >> 1852919

Effects of feeder cells on the X-ray sensitivity of human colon cancer cells.

J T Leith1, G Padfield, L E Faulkner, P Quinn, S Michelson.   

Abstract

The survival responses to 250 kVp X-irradiation of 20 different exponentially growing human colon tumor lines have been described using the linear-quadratic equation of cell survival. Because some of these tumor lines (6/20) showed statistically significant increases in colony forming efficiency (CFE) when feeder cells (FCs) were added (10(5) FCs/60 mm dish), radiation survival parameters were determined for all 20 tumor lines with and without added feeder cells. In neither FC independent nor FC dependent lines did addition of FCs significantly affect any of the derived radiation survival parameters, including the alpha and beta inactivation constants, the mean inactivation dose (D, Gy), or the surviving fraction of cells at 2 Gy (S2). The average alpha, beta, and S2 values for these 20 human colon cancer cell lines with added feeder cells were: 0.281 Gy-1, 0.0711 Gy-2, and 0.443. A cumulative frequency distribution plot of the mean inactivation dose (D) which includes other published radiobiological data on human colon cancer cell lines (N = 26) indicates that the D50 value is 2.17 Gy.

Entities:  

Mesh:

Year:  1991        PMID: 1852919     DOI: 10.1016/0167-8140(91)90341-d

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  2 in total

1.  Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells.

Authors:  Gisela Nogales-Gadea; Abhishek Saxena; Carolin Hoffmann; Judith Hounjet; Daniëlle Coenen; Peter Molenaar; Mario Losen; Pilar Martinez-Martinez
Journal:  J Vis Exp       Date:  2015-06-05       Impact factor: 1.355

2.  Comparison of basic fibroblast growth factor levels in clone A human colon cancer cells in vitro with levels in xenografted tumours.

Authors:  L P McCarty; S M Karr; B Z Harris; S G Michelson; J T Leith
Journal:  Br J Cancer       Date:  1995-07       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.